Results 1 to 10 of about 21,804,485 (185)

Caco-2 Cells, Biopharmaceutics Classification System (BCS) and Biowaiter [PDF]

open access: yesActa Medica, 2011
Almost all orally administered drugs are absorbed across the intestinal mucosa. The Caco-2 monolayers are used as an in vitro model to predict drug absorption in humans and to explore mechanism of drug absorption.
Libuše Smetanová   +3 more
doaj   +4 more sources

The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines

open access: yesInternational Journal of Pharmaceutics, 2019
The recent impact of the Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS) on relevant scientific advancements is discussed. The major advances associated with the BCS concern the extensive work on dissolution of poorly absorbed BCS class II drugs in nutritional liquids (e.g.
Charalabidis, A.   +3 more
exaly   +7 more sources

The Role of BCS (Biopharmaceutics Classification System) and BDDCS (Biopharmaceutics Drug Disposition Classification System) in Drug Development [PDF]

open access: yesJournal of Pharmaceutical Sciences, 2013
Biopharmaceutics Classification System and Biopharmaceutics Drug Distribution Classification System are complimentary, not competing, classification systems that aim to improve, simplify, and speed drug development. Although both systems are based on classifying drugs and new molecular entities into four categories using the same solubility criteria ...
Leslie Z. Benet
exaly   +8 more sources

Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): Theoretical basis and practical examples

open access: yesInternational Journal of Pharmaceutics, 2008
The aim of this work is to develop biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD). The kinetics of gastrointestinal (GI) wall permeation and dissolution were re-considered theoretically. The relationships between the solubility/dose ratio and the fractions of dose dissolved and absorbed, were ...
Papadopoulou, V.   +3 more
exaly   +8 more sources

Lipid Based Formulations of Biopharmaceutics Classification System (BCS) Class II Drugs: Strategy, Formulations, Methods and Saturation [PDF]

open access: yesFolia Veterinaria, 2016
Active ingredients in pharmaceuticals differ by their physico-chemical properties and their bioavailability therefore varies. The most frequently used and most convenient way of administration of medicines is oral, however many drugs are little soluble ...
Šoltýsová I.   +2 more
doaj   +3 more sources

An Overview of the Biopharmaceutics Classification System (BCS)

open access: yesGSC Biological and Pharmaceutical Sciences, 2021
The Biopharmaceutics Classification System (BCS) is an essential tool in pharmaceutical sciences, providing a scientific framework for classifying drugs based on their solubility and permeability characteristics. This system, developed in 1995, helps streamline drug development and regulatory approval processes by predicting in vivo drug performance ...
null L. Prasanna Tarivitla   +1 more
openaire   +3 more sources

The biopharmaceutics classification system (BCS): Class III drugs — better candidates for BA/BE waiver?

open access: yesEuropean Journal of Pharmaceutical Sciences, 1999
Current guidelines (CPMP Note for Guidance in Europe and FDA Guidance for Industry in the USA) consider a waiver of bioavailability/bioequivalence studies for immediate release dosage forms of highly soluble, highly permeable drug substances (Class I according to the BCS).
H H, Blume, B S, Schug
openaire   +4 more sources

Lack of Effect of Antioxidants on Biopharmaceutics Classification System (BCS) Class III Drug Permeability

open access: yesJournal of Pharmaceutical Sciences
The addition of antioxidants to pharmaceutical products is a potential approach to inhibit nitrosamine formation, particularly in solid oral dosage forms like tablets and capsules. The objective was to assess the effect of ten antioxidants on the permeability of four Biopharmaceutics Classification System (BCS) Class III drugs.
Yuly Chiang Yu   +3 more
openaire   +4 more sources

Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development

open access: yesDrug Design, Development and Therapy, 2014
Omri Wolk, Riad Agbaria, Arik Dahan Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel Abstract: The main objective of this work was to investigate in-silico ...
Wolk O, Agbaria R, Dahan A
doaj   +2 more sources

Home - About - Disclaimer - Privacy